By Cassandra Jaramillo
Medical-device maker Medtronic PLC (MDT) said Friday that it
reached a deal to acquire the privately held medical-device company
Aptus Endosystems Inc. for $110 million to expand its technology
for aortic aneurysms.
Aptus Endosystems focuses on technology for endovascular
aneurysm repair and thoracic endovascular repair. Medtronic said
Aptus products complement its aortic stent platform for the
treatment of complex aortic disease.
"The...systems strongly align with our strategy to invest in
treatments that address complex aortic disease with a vision to
treat disease of the entire aorta," said Daveen Chopra, vice
president and general manager of Medtronic's aortic business,
within the cardiac and vascular group.
Medtronic earlier Friday said it had purchased CardioInsight
Technologies for $93 million to expand its cardiac mapping system
technologies.
In its latest reported quarter, Medtronic posted a loss of $1
million in its first combined quarter with Covidien. The $43
billion acquisition closed in January.
Shares of Medtronic, up 18.6% in the last 12 months, remained
unchanged in after-hours.
Write to Cassandra Jaramillo at Cassandra.Jaramillo@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires